Model-Informed Drug Discovery and Development in Pulmonary Delivery: Biopharmaceutical Pharmacometric Modeling for Formulation Evaluation of Pulmonary Suspensions-Reference-Cited by-同舟云学术

Model-Informed Drug Discovery and Development in Pulmonary Delivery: Biopharmaceutical Pharmacometric Modeling for Formulation Evaluation of Pulmonary Suspensions

Published:2020-09-22 Issue:40 Volume:5 Page:25733-25746
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Sou Tomás¹²,Soukarieh Fadi³⁴^ORCID,Williams Paul³⁴,Stocks Michael J.⁵⁴^ORCID,Cámara Miguel³⁴,Bergström Christel A. S.⁶⁷^ORCID

Affiliation:

1. Molecular Pharmaceutics, Department of Pharmacy, Uppsala University, SE-751 23 Uppsala, Sweden

2. Pharmacometrics, Department of Pharmacy, Uppsala University, SE-751 23 Uppsala, Sweden

3. Nottingham University Biodiscovery Institute, School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, United Kingdom

4. The National Biofilms Innovation Centre, Nottingham NG7 2RD, United Kingdom

5. Nottingham University Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, United Kingdom

6. Drug Delivery, Department of Pharmacy, Uppsala University, SE-751 23 Uppsala, Sweden

7. The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, SE-751 23 Uppsala, Sweden

Funder

Medical Research Council

Vetenskapsr?det

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.0c03004

Reference42 articles.

1. Pulmonary drug delivery systems for antimicrobial agents: facts and myths

2. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options

3. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients

4. Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time

5. Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Evaluation of New 1H-Benzo[d]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections;Journal of Medicinal Chemistry;2024-01-03

2. Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology;Antibody Therapeutics;2022-01-01

3. Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design;Pharmaceuticals;2021-10-19

4. The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials;Pharmaceutics;2021-06-03

5. Contemporary Formulation Development for Inhaled Pharmaceuticals;Journal of Pharmaceutical Sciences;2021-01